advanced melanoma

ASCO: Regeneron's Opdualag rival records double the historical response rate in melanoma
ASCO: Regeneron's Opdualag rival records double the historical response rate in melanoma
Fierce Biotech
ASCO 2023
Regeneron
advanced melanoma
fianlimab
Flag link:
Bristol-Myers misses main goal of late-stage skin cancer trial
Bristol-Myers misses main goal of late-stage skin cancer trial
Yahoo/Reuters
Bristol-Myers Squibb
clinical trials
Yervoy
Opdivo
advanced melanoma
Flag link:
Anti-PD-1 Drug Opdivo Significantly Improves Five Year Survival In Advanced Cancers
Anti-PD-1 Drug Opdivo Significantly Improves Five Year Survival In Advanced Cancers
Forbes
advanced cancer
Opdivo
Bristol-Myers Squibb
advanced melanoma
Flag link:
Roche/Exelixis' Cotellic fizzles in pivotal melanoma study
Roche/Exelixis' Cotellic fizzles in pivotal melanoma study
Endpoints
Roche
Exelixis
Cotellic
Tecentriq
clinical trials
advanced melanoma
Flag link:
Opdivo Approved in Europe for Additional Use in Melanoma Patients
Opdivo Approved in Europe for Additional Use in Melanoma Patients
CP Wire
Opdivdo
Bristol-Myers Squibb
melanoma
advanced melanoma
Europe
Flag link:
Opdivo Approved in Europe for Additional Use in Melanoma Patients
Opdivdo
Bristol-Myers Squibb
melanoma
advanced melanoma
Flag link:
Encorafenib and Binimetinib Combination Results Show Improved Survival in BRAF-Mutant Advanced Melanoma Patient
Encorafenib and Binimetinib Combination Results Show Improved Survival in BRAF-Mutant Advanced Melanoma Patient
CP Wire
Array Biopharma
encorafenib
binimetinib
advanced melanoma
ASCO 2018
Flag link:
Incyte, Merck build case for skin cancer combo
Incyte, Merck build case for skin cancer combo
BioPharma Dive
Incyte
Merck
Keytruda
advanced melanoma
Flag link: